Scarica l'app Stockscreener
11.29
0.80%
0.10
Precedente Chiudi:
$11.20
Aprire:
$10.92
Volume 24 ore:
963.53K
Relative Volume:
0.59
Capitalizzazione di mercato:
$3.55B
Reddito:
$2.68B
Utile/perdita netta:
$-184.45M
Rapporto P/E:
-16.60
EPS:
-0.6805
Flusso di cassa netto:
$229.23M
1 W Prestazione:
+9.67%
1M Prestazione:
+8.61%
6M Prestazione:
+41.59%
1 anno Prestazione:
+34.19%
Intervallo 1D:
$10.92
$11.34
Intervallo di 1 settimana:
$9.99
$11.34
Portata 52W:
$6.685
$11.34
Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile
Nome
Amneal Pharmaceuticals Inc
Settore
Telefono
908-947-3120
Indirizzo
400 Crossing Boulevard, 3rd Floor, Bridgewater
Confronta AMRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMRX
Amneal Pharmaceuticals Inc
|
11.29 | 3.52B | 2.68B | -184.45M | 229.23M | -0.6805 |
|
ZTS
Zoetis Inc
|
125.18 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.55 | 42.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.305 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.34 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
436.28 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-06 | Iniziato | Goldman | Buy |
| 2025-02-24 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-06 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2021-03-08 | Aggiornamento | Goldman | Sell → Buy |
| 2020-12-14 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-12-14 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-07-27 | Iniziato | Goldman | Sell |
| 2020-05-12 | Aggiornamento | Guggenheim | Sell → Neutral |
| 2019-12-12 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-11-07 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-07-22 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-07-11 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-07-08 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2019-06-11 | Iniziato | Barclays | Equal Weight |
| 2019-05-21 | Aggiornamento | Raymond James | Mkt Perform → Strong Buy |
| 2019-03-20 | Iniziato | SunTrust | Buy |
| 2019-03-08 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2018-12-14 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-16 | Downgrade | SunTrust | Buy → Hold |
| 2018-08-13 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-07-23 | Iniziato | Morgan Stanley | Overweight |
| 2018-06-22 | Iniziato | B. Riley FBR, Inc. | Buy |
Mostra tutto
Amneal Pharmaceuticals Inc Borsa (AMRX) Ultime notizie
Implied Volatility Surging for Amneal Pharmaceuticals Stock Options - TradingView
Will Amneal Pharmaceuticals Inc. stock outperform Dow Jones index2025 Historical Comparison & Stock Market Timing Techniques - newser.com
Real time breakdown of Amneal Pharmaceuticals Inc. stock performanceJuly 2025 Analyst Calls & Free Long-Term Investment Growth Plans - newser.com
Is Amneal Pharmaceuticals Inc. stock in correction or buying zonePortfolio Return Report & Weekly Breakout Stock Alerts - newser.com
Is Amneal Pharmaceuticals Inc. stock ready for a breakoutWeekly Trade Recap & Intraday High Probability Alerts - newser.com
Multi asset correlation models including Amneal Pharmaceuticals Inc.Quarterly Trade Review & AI Driven Stock Movement Reports - newser.com
BioSpace 2026 Best Places to Work Spotlights Most Desirable Workplaces - BioSpace
Candlestick signals on Amneal Pharmaceuticals Inc. stock todayJuly 2025 Movers & Daily Stock Trend Reports - newser.com
Will Amneal Pharmaceuticals Inc. stock benefit from automationJuly 2025 Earnings & Fast Moving Stock Watchlists - newser.com
How high can Amneal Pharmaceuticals Inc. stock goInsider Buying & Weekly Watchlist for Consistent Profits - newser.com
What analyst consensus says on Amneal Pharmaceuticals Inc. stockWeekly Trend Summary & Community Consensus Stock Picks - newser.com
Is Amneal Pharmaceuticals Inc. stock resilient to inflationPortfolio Risk Report & Weekly Chart Analysis and Trade Guides - newser.com
Is Amneal Pharmaceuticals Inc. stock a top momentum play2025 Trading Volume Trends & Real-Time Market Trend Scan - newser.com
Does Amneal Pharmaceuticals Inc. show high probability of rebound2025 Technical Overview & Real-Time Stock Movement Alerts - newser.com
Will Amneal Pharmaceuticals Inc. stock reach Wall Street targetsEarnings Risk Summary & Risk Controlled Swing Trade Alerts - newser.com
How to manage a losing position in Amneal Pharmaceuticals Inc.Weekly Investment Report & Verified Stock Trade Ideas - newser.com
Published on: 2025-11-02 12:06:47 - newser.com
Amneal Pharmaceuticals Reports Strong Q3 2025 Results - MSN
Amneal Pharmaceuticals Hits New 52-Week High of $10.70 - Markets Mojo
Piper Sandler Reaffirms Overweight Rating for Amneal Pharmaceuticals (NASDAQ:AMRX) - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB), Option Care Health (OPCH) and Amneal Pharmaceuticals (AMRX) - The Globe and Mail
Amneal raises 2025 EPS guidance and outlines $300M–$500M CREXONT sales target as portfolio expansion accelerates - MSN
Amneal Pharmaceuticals (AMRX) Receives a Buy from Truist Financial - The Globe and Mail
Amneal Pharmaceuticals stock hits 52-week high at $10.72 By Investing.com - Investing.com Australia
Amneal Pharmaceuticals (AMRX): One-Off $55.9M Loss Tests Bull Case Built on High Earnings Growth Forecasts - Sahm
Amneal Pharmaceuticals, Inc. (AMRX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Amneal Pharmaceuticals (NASDAQ:AMRX) Releases Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
Why Amneal (AMRX) Stock Is Up Today - Yahoo Finance
Amneal Pharmaceuticals (NASDAQ:AMRX) Reaches New 12-Month High on Strong Earnings - MarketBeat
Amneal Pharmaceuticals stock hits 52-week high at $10.72 - Investing.com
Truist Raises Price Target on Amneal Pharmaceuticals to $14 From $13, Keeps Buy Rating - MarketScreener
Amneal Pharmaceuticals (NASDAQ:AMRX) Updates FY 2025 Earnings Guidance - MarketBeat
Published on: 2025-10-31 02:59:36 - newser.com
Amneal Pharmaceuticals (AMRX) Profitability Milestone Tests Investor Optimism on Growth and Valuation - Yahoo Finance
Amneal Pharmaceuticals Q3 2025 Earnings Preview - MSN
Amneal: Q3 Earnings Snapshot - CT Insider
Amneal Pharmaceuticals Inc (AMRX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Amneal Q3 2025 slides: Revenue up 12% as specialty products gain traction - Investing.com Canada
How Amneal Pharmaceuticals’ (AMRX) Return to Profitability and Respiratory Product Wins Have Changed Its Investment Story - simplywall.st
Amneal raises 2025 guidance and targets $300M–$500M peak CREXONT sales as new launches accelerate - MSN
Earnings call transcript: Amneal Pharma Q3 2025 beats EPS forecast, stock rises - Investing.com
Amneal Pharmaceuticals, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:AMRX) 2025-10-30 - Seeking Alpha
Amneal (AMRX) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
Amneal Pharmaceuticals Q3 2025 Earnings Call Transcript - MarketBeat
Amneal Pharmaceuticals Inc Azioni (AMRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.27%
0.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):